Detalles de la búsqueda
1.
Erosive Progression by High-Resolution Peripheral Quantitative Computed Tomography and Conventional Radiography in Rheumatoid Arthritis.
Rheumatology (Oxford)
; 2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38749001
2.
CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome.
Blood
; 139(1): 87-103, 2022 01 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34320176
3.
Time from diagnosis to treatment has no impact on survival in newly diagnosed acute myeloid leukemia treated with venetoclax-based regimens.
Haematologica
; 2024 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38654660
4.
Impact of BMI on patient outcome in acute myeloid leukaemia patients receiving intensive induction therapy: a real-world registry experience.
Br J Cancer
; 129(7): 1126-1133, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37542108
5.
Prediction of complete remission and survival in acute myeloid leukemia using supervised machine learning.
Haematologica
; 108(3): 690-704, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35708137
6.
Impact of trisomy 19 on outcome according to genetic makeup in patients with acute myeloid leukemia.
Haematologica
; 108(8): 2059-2066, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36815361
7.
Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4.
Haematologica
; 108(1): 34-41, 2023 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35678031
8.
Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) Study.
Ann Hematol
; 102(10): 2741-2752, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37592092
9.
Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?
Blood
; 136(7): 823-830, 2020 08 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-32496541
10.
Radioimmunotherapy in Combination with Reduced-Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients with Advanced Multiple Myeloma.
Biol Blood Marrow Transplant
; 26(4): 691-697, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31730919
11.
Primary analysis of JUMP, a phase 3b, expanded-access study evaluating the safety and efficacy of ruxolitinib in patients with myelofibrosis, including those with low platelet counts.
Br J Haematol
; 189(5): 888-903, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32017044
12.
Health-related quality of life in the phase III GALLIUM study of obinutuzumab- or rituximab-based chemotherapy in patients with previously untreated advanced follicular lymphoma.
Ann Hematol
; 99(12): 2837-2846, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32314038
13.
Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV.
Haematologica
; 104(5): 955-962, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30514803
14.
Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial.
J Neurooncol
; 144(3): 501-509, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31325144
15.
Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2): an open-label, multicentre, phase 2 trial.
Lancet Oncol
; 19(12): 1668-1679, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30442503
16.
Midostaurin in addition to intensive chemotherapy in acute myeloid leukemia with t(8;21) and KIT and/or FLT3- ITD mutations: results of the SAL MIDOKIT trial.
Haematologica
; 108(9): 2520-2525, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36779591
17.
Long-Term Follow-Up and Impact of Comorbidity before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia-Lessons Learned from the Prospective BRIDGE Trial.
Biol Blood Marrow Transplant
; 23(9): 1491-1497, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28527985
18.
Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network.
Lancet
; 388(10044): 565-75, 2016 Aug 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27313086
19.
Allogeneic Stem Cell Transplantation Improves Survival in Patients with Acute Myeloid Leukemia Characterized by a High Allelic Ratio of Mutant FLT3-ITD.
Biol Blood Marrow Transplant
; 22(3): 462-9, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26551637
20.
TP53 mutation in patients with high-risk acute myeloid leukaemia treated with allogeneic haematopoietic stem cell transplantation.
Br J Haematol
; 172(6): 914-22, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26771088